Share This Page
Suppliers and packagers for VITAMIN D
✉ Email this page to a colleague
VITAMIN D
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Bionpharma | VITAMIN D | ergocalciferol | CAPSULE;ORAL | 080704 | ANDA | AvKARE | 42291-266-01 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (42291-266-01) | 2015-07-23 |
| Bionpharma | VITAMIN D | ergocalciferol | CAPSULE;ORAL | 080704 | ANDA | PD-Rx Pharmaceuticals, Inc. | 43063-711-12 | 12 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (43063-711-12) | 2016-06-15 |
| Bionpharma | VITAMIN D | ergocalciferol | CAPSULE;ORAL | 080704 | ANDA | Aphena Pharma Solutions - Tennessee, LLC | 43353-238-03 | 3 CAPSULE, LIQUID FILLED in 1 BOTTLE (43353-238-03) | 2015-07-23 |
| Bionpharma | VITAMIN D | ergocalciferol | CAPSULE;ORAL | 080704 | ANDA | Aphena Pharma Solutions - Tennessee, LLC | 43353-238-04 | 4 CAPSULE, LIQUID FILLED in 1 BOTTLE (43353-238-04) | 2015-07-23 |
| Bionpharma | VITAMIN D | ergocalciferol | CAPSULE;ORAL | 080704 | ANDA | Aphena Pharma Solutions - Tennessee, LLC | 43353-238-08 | 8 CAPSULE, LIQUID FILLED in 1 BOTTLE (43353-238-08) | 2015-07-23 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Vitamin D
Introduction
Vitamin D, a fat-soluble vitamin essential for calcium homeostasis, immune function, and bone health, ranks among the most widely used nutraceuticals and pharmaceutical agents worldwide. Its therapeutic applications extend from preventing rickets to managing osteoporosis and supplementing deficiencies in various populations. The global demand for Vitamin D compounds—most notably cholecalciferol (Vitamin D3) and ergocalciferol (Vitamin D2)—has surged in recent years, driven by increased awareness of deficiency-related health issues. Understanding the supply landscape is crucial for pharmaceutical companies, healthcare providers, and investors seeking reliable sources for high-quality Vitamin D ingredients. This article provides an in-depth analysis of the key suppliers, their manufacturing capacities, quality standards, geographic distribution, and market dynamics.
Global Supply Landscape
The supply chain for pharmaceutical-grade Vitamin D is complex, involving numerous chemical manufacturers, bulk ingredient suppliers, and contract manufacturing organizations (CMOs). These entities operate across continents, with significant presence in North America, Europe, Asia-Pacific, and other regions. The core suppliers predominantly produce cholecalciferol and ergocalciferol, which serve as active pharmaceutical ingredients (APIs) or intermediates for finished formulations.
Leading Suppliers of Vitamin D
1. BASF SE
Overview
BASF SE, headquartered in Germany, stands as a global leader in specialty chemicals and nutritional ingredients. The company's Vitamin D portfolio includes high-purity cholecalciferol, which meets stringent pharmaceutical standards.
Capabilities and Offerings
BASF's Vitamin D3 (cholecalciferol) is produced via proprietary fermentation processes, ensuring high purity and bioavailability. The company supplies both bulk raw material for pharmaceutical manufacturing and finished dosage forms. Their quality management aligns with pharmacopeial standards such as USP, EP, and JP, ensuring consistent compliance for medical applications.
Market Position
BASF's global distribution network, rigorous quality controls, and R&D investments solidify its role as a primary API supplier for Vitamin D.
2. Evonik Industries
Overview
German-based Evonik Industries manufactures specialty chemicals, including botanical and nutritional extracts. It supplies Vitamin D3 for pharmaceutical and nutraceutical use.
Manufacturing Strengths
Evonik employs advanced synthesis and fermentation technologies, producing pharmaceutical-grade cholecalciferol with high purity (typically > 99%). Their facilities are certified per Good Manufacturing Practices (GMP), facilitating regulatory approval across multiple markets.
3. DSM (now part of Royal DSM)
Overview
Royal DSM, headquartered in the Netherlands, is a prominent supplier of nutritional ingredients, including Vitamin D3 specialty products tailored for pharmaceutical applications.
Product Portfolio
DSM offers pharmaceutical-grade Vitamin D3 with extensive documentation, ensuring stability, bioavailability, and compliance with international pharmacopeias. Their production facilities are certified according to GMP, ISO, and other quality standards.
4. Zhejiang Medicine Co., Ltd.
Overview
Chinese pharmaceutical manufacturer Zhejiang Medicine is recognized for supplying a significant volume of Vitamin D3 and D2.
Strengths and Market Role
They operate large-scale production facilities capable of meeting global demand, supporting both nutraceutical and pharmaceutical sectors. Their products undergo rigorous quality testing, with increasing certification aligning with international standards, including NSF, ISO, and GMP certifications.
5. Colorcon and Other Pharmaceutical Excipients Suppliers
While not API manufacturers, excipient suppliers like Colorcon source Vitamin D3 for formulation support, emphasizing the importance of integrating high-purity ingredients from trusted suppliers into final products.
Regional Distribution of Suppliers
- Europe: Dominated by BASF, Evonik, DSM, and larger regional players with well-established GMP-compliant facilities.
- Asia-Pacific: Rapidly growing production centers led by Zhejiang Medicine, Sichuan Kelun Pharmaceutical, and other Chinese manufacturers leveraging cost efficiencies and high production capacities.
- North America: Sourcing primarily from global players, with some regional manufacturers emerging to meet local demand, including companies in the United States and Canada.
Quality Standards and Certifications
Compliance with international pharmacopeia standards (USP, EP, JP) remains a core criterion for pharmaceutical suppliers. Many leading suppliers invest in third-party audits and certifications, including:
- GMP Certification: Ensures manufacturing processes meet strict quality and safety guidelines.
- ISO Certifications: Demonstrate consistent quality management practices.
- Certifications for Organic and Non-GMO: Increasingly relevant for nutraceutical-grade Vitamin D for certain markets.
Manufacturers often provide comprehensive stability data, impurity profiles, and bioavailability studies to adhere to regulatory requirements in target markets.
Market Dynamics and Supplier Trends
Supply Chain Resilience
Recent disruptions, including the COVID-19 pandemic, highlighted vulnerabilities in global supply chains. Many pharmaceutical companies are diversifying their supplier base to mitigate risks linked to reliance on single-source manufacturing, especially from regions experiencing geopolitical or logistical challenges.
Pricing and Cost Factors
Price volatility affects procurement strategies, with raw material costs influenced by feedstock prices, fermentation yields, and regulatory requirements. Chinese manufacturers tend to offer competitive pricing due to lower production costs, while European suppliers maintain premium pricing aligned with quality and regulatory standards.
Innovations and Future Trends
Advancements in fermentation technology and synthetic chemistry are improving yields, purity, and cost-effectiveness. The trend toward sustainable and plant-based sources of Vitamin D may also influence future supplier strategies, aligning with increasing consumer demand for "clean label" and plant-derived ingredients.
Conclusion
The supply of pharmaceutical-grade Vitamin D is centered around established chemical and biotech manufacturers with global footprints. Key players such as BASF, Evonik, DSM, and Zhejiang Medicine lead the market, offering high-quality APIs that meet rigorous international standards. Diversification of supply sources, adherence to regulatory standards, and investments in innovative production technologies remain critical for stakeholders seeking reliable Vitamin D supply chains.
Key Takeaways
- Major Manufacturers: BASF, Evonik, DSM, Zhejiang Medicine dominate global Vitamin D supply, offering high-purity cholecalciferol and ergocalciferol suitable for pharmaceutical use.
- Regional Variability: Europe leads in high-quality API production; China and Asia-Pacific are expanding capacities and market share.
- Quality and Compliance: Ensuring suppliers meet GMP and pharmacopeial standards is essential for regulatory approval and product safety.
- Supply Chain Risks: Diversification and strategic sourcing are vital to mitigate disruptions and meet growing demand.
- Innovation: Advances in fermentation and synthetic methods are improving yields, purity, and sustainability, shaping future supplier landscapes.
FAQs
-
What are the top chemical forms of Vitamin D used in pharmaceuticals?
The primary forms are cholecalciferol (Vitamin D3) and ergocalciferol (Vitamin D2), with D3 being more prevalent due to superior potency and bioavailability. -
Which certifications should suppliers hold to ensure pharmaceutical-grade Vitamin D?
Suppliers should be GMP-certified, with products compliant with USP, EP, or JP standards. Additional ISO certifications and third-party audits enhance credibility. -
Are there regional differences in Vitamin D supplier quality?
Yes. European suppliers generally adhere to stricter regulatory standards, whereas some Asian suppliers offer cost-competitive options that meet international requirements when properly validated. -
How has COVID-19 affected Vitamin D supply chains?
The pandemic underscored vulnerabilities in supply chains, driving companies to diversify suppliers and enhance inventory buffers to ensure steady supply. -
What future trends are shaping Vitamin D supply for pharmaceuticals?
Growing demand for sustainably sourced, plant-based, and high-purity Vitamin D will push technological innovations and new market entrants, emphasizing quality and regulatory compliance.
References
[1] European Pharmacopoeia. "Vitamin D3 (Cholecalciferol): Monograph." 12th Edition.
[2] U.S. Pharmacopeia. "Vitamin D3 (Cholecalciferol) Monograph." USP 45-NF 40.
[3] MarketWatch. "Global Vitamin D Market Size and Share 2023."
[4] Company websites and public filings from BASF, Evonik, DSM, Zhejiang Medicine.
[5] Industry reports on pharmaceutical ingredient manufacturing and supply chain risk assessments.
More… ↓
